US4572908A
(en)
*
|
1982-12-21 |
1986-02-25 |
Pfizer Inc. |
Dihydropyridines
|
GB8306666D0
(en)
*
|
1983-03-10 |
1983-04-13 |
Pfizer Ltd |
Therapeutic agents
|
EP0125803A3
(de)
*
|
1983-04-27 |
1987-01-21 |
FISONS plc |
Pharmazeutisch aktive Dihydropyridine
|
EP0168841B1
(de)
*
|
1983-12-19 |
1988-09-28 |
Pfizer Limited |
Dihydropyridin-Zwischenprodukt
|
JPS60156671A
(ja)
*
|
1984-01-25 |
1985-08-16 |
Yamanouchi Pharmaceut Co Ltd |
ジヒドロピリジン誘導体およびその製造法
|
GB8414518D0
(en)
*
|
1984-06-07 |
1984-07-11 |
Pfizer Ltd |
Therapeutic agents
|
GB8421039D0
(en)
*
|
1984-08-17 |
1984-09-19 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
GR851819B
(de)
*
|
1984-08-17 |
1985-11-26 |
Wyeth John & Brother Ltd |
|
IL77843A
(en)
*
|
1985-02-11 |
1989-07-31 |
Syntex Inc |
Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them
|
EP0200524A3
(de)
*
|
1985-05-03 |
1987-06-16 |
Pfizer Limited |
Dihydropyridin-Calcium-Antagonisten
|
DE3531498A1
(de)
*
|
1985-09-04 |
1987-03-05 |
Bayer Ag |
Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln
|
EP0225175A3
(de)
*
|
1985-11-28 |
1988-12-28 |
FISONS plc |
Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
|
DE3544211A1
(de)
*
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
IT1204460B
(it)
*
|
1986-02-20 |
1989-03-01 |
Glaxo Spa |
Derivati eterociclici
|
GB8608335D0
(en)
*
|
1986-04-04 |
1986-05-08 |
Pfizer Ltd |
Pharmaceutically acceptable salts
|
FR2649395B1
(fr)
*
|
1989-07-04 |
1992-11-06 |
Adir |
Nouveau derive de la dihydro-1,4 pyridine denomme (-) i1(((amino-2 ethoxy)-2 ethoxy) methyli1) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent
|
FR2602231B1
(fr)
*
|
1986-08-04 |
1988-10-28 |
Adir |
Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
US4983740A
(en)
*
|
1986-08-04 |
1991-01-08 |
Adir Et Compagnie |
Process for 1,4-dihydropyridine compounds
|
US5196410A
(en)
*
|
1986-10-31 |
1993-03-23 |
Pfizer Inc. |
Transdermal flux enhancing compositions
|
IT1213555B
(it)
*
|
1986-12-11 |
1989-12-20 |
Boehringer Biochemia Srl |
2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
|
JPS63196564A
(ja)
*
|
1987-02-10 |
1988-08-15 |
Agency Of Ind Science & Technol |
イミドオリゴマ−の製造方法
|
IT1215381B
(it)
*
|
1987-03-12 |
1990-02-08 |
Boehringer Biochemia Srl |
Farmaceutiche che le contengono. carbonil- e solfonil- derivati di 2-(aminoalchiltio)metil-1,4-diidropiridine, un metodo per la loro preparazione e composizioni
|
GB8709447D0
(en)
*
|
1987-04-21 |
1987-05-28 |
Pfizer Ltd |
Dihydropyridines
|
GB8710493D0
(en)
*
|
1987-05-02 |
1987-06-03 |
Pfizer Ltd |
Dihydropyridines
|
DE3906406C1
(de)
*
|
1989-03-01 |
1990-10-25 |
Goedecke Ag, 1000 Berlin, De |
|
DE4128132A1
(de)
*
|
1991-08-24 |
1993-02-25 |
Bayer Ag |
3-(2-chlor-3-trifluormethylphenyl)-4-cyanopyrrol, dessen herstellung und verwendung und neue zwischenprodukte
|
US5234943A
(en)
*
|
1989-04-13 |
1993-08-10 |
Bayer Aktiengesellschaft |
Fungicidal 3-(2-chloro-3-trifluoromethylphenyl)-4-cyanopyrrole
|
FR2652083B1
(fr)
*
|
1989-09-20 |
1992-01-24 |
Ador Cie |
Nouveau procede de separation d'isomeres optiques des derives de la dihydro-1,4 pyridine.
|
US5270323A
(en)
*
|
1990-05-31 |
1993-12-14 |
Pfizer Inc. |
Method of treating impotence
|
AU3147593A
(en)
*
|
1991-11-26 |
1993-06-28 |
Sepracor, Inc. |
Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
|
US6057344A
(en)
|
1991-11-26 |
2000-05-02 |
Sepracor, Inc. |
Methods for treating hypertension, and angina using optically pure (-) amlodipine
|
US6162802A
(en)
*
|
1992-03-10 |
2000-12-19 |
Papa; Joseph |
Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
|
EP1614420A3
(de)
*
|
1992-11-25 |
2006-04-19 |
Sepracor Inc. |
Behandlung von Bluthochdruck, Angina und anderen Erkrankungen mit (-)Amlodipin
|
US5389654A
(en)
*
|
1992-11-26 |
1995-02-14 |
Lek, Tovarna, Farmacevtskih In Kemicnih . . . |
3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
|
SI9200344B
(sl)
*
|
1992-11-26 |
1998-06-30 |
Lek, |
Postopek za pripravo amlodipin benzensulfonata
|
US6221335B1
(en)
*
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
JPH11500140A
(ja)
|
1995-03-16 |
1999-01-06 |
ファイザー・インコーポレーテッド |
アムロジピン、アムロジピン塩、もしくはフェロジピンとace阻害薬とを含有する組成物
|
NZ280378A
(en)
*
|
1995-11-01 |
1998-04-27 |
Apotex Inc |
4-phenyl-1,4-dihydropyridine-3,5-dicarboxylic acid compounds, preparation, intermediate compounds
|
HU221810B1
(hu)
*
|
1997-08-12 |
2003-01-28 |
EGIS Gyógyszergyár Rt. |
Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
|
GT199800127A
(es)
*
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
ZA9810319B
(en)
*
|
1997-11-14 |
2000-05-11 |
Gea Farmaceutisk Fabrik As |
Process for the preparation of acetal derivatives of 1,4-dihydropyridines, novel acetal derivatives and the use of the acetal derivatives for the preparation of other 1,4-dihydropyridines.
|
ZA9810320B
(en)
*
|
1997-11-14 |
2000-05-11 |
Gea Farmaceutisk Fabrik As |
Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
|
ES2151850B1
(es)
*
|
1998-10-26 |
2001-08-16 |
Esteve Quimica Sa |
Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
|
CA2375372C
(en)
|
1999-05-27 |
2007-01-09 |
George Chang |
Mutual prodrugs of amlodipine and atorvastatin
|
HN2000000050A
(es)
|
1999-05-27 |
2001-02-02 |
Pfizer Prod Inc |
Sal mutua de amlodipino y atorvastatina
|
UA72768C2
(en)
*
|
1999-07-05 |
2005-04-15 |
Richter Gedeon Vegyeszet |
A method for obtaining amilodipine benzenesulphonate
|
CN1091441C
(zh)
*
|
1999-12-04 |
2002-09-25 |
昆明赛诺制药有限公司 |
甲磺酸氨氯地平及其制法和应用
|
US6521647B2
(en)
|
2000-04-04 |
2003-02-18 |
Pfizer Inc. |
Treatment of renal disorders
|
CZ301790B6
(cs)
*
|
2000-04-11 |
2010-06-23 |
Sankyo Company Limited |
Farmaceutický prípravek obsahující blokátor vápníku
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
AU2001284413A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Sankyo Company Limited |
Medicinal compositions for preventing or treating heart failure
|
US6737430B2
(en)
|
2000-11-09 |
2004-05-18 |
Pfizer, Inc. |
Mutual prodrug of amlodipine and atorvastatin
|
GB0027410D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Pfizer Ltd |
Mutual prodrug of amlodipine and atorvastatin
|
WO2002054062A2
(en)
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Reference standards and processes for determining the purity or stability of amlodipine maleate
|
MXPA03005886A
(es)
*
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado de aspartato de amlodipina como antagonista del canal de calcio.
|
RS53403A
(en)
|
2000-12-29 |
2006-10-27 |
Pfizer Limited |
Process for making amlodipine maleate
|
US7335380B2
(en)
|
2000-12-29 |
2008-02-26 |
Synthon Ip Inc. |
Amlodipine free base
|
CA2433193C
(en)
|
2000-12-29 |
2006-01-31 |
Pfizer Limited |
Amide derivative of amlodipine
|
MXPA03005882A
(es)
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado amida de amlodipina.
|
AT5874U1
(de)
|
2000-12-29 |
2003-01-27 |
Bioorg Bv |
Pharmazeutische zubereitungen enthaltend amlodipinmaleat
|
CA2433181C
(en)
|
2000-12-29 |
2005-11-22 |
Pfizer Limited |
Amlodipine hemifumarate
|
EA008141B1
(ru)
*
|
2000-12-29 |
2007-04-27 |
Пфайзер Лимитед |
Способ получения малеата амлодипина
|
US6653481B2
(en)
*
|
2000-12-29 |
2003-11-25 |
Synthon Bv |
Process for making amlodipine
|
CZ20031779A3
(cs)
*
|
2000-12-29 |
2004-10-13 |
Bioorganicsáb@V |
Způsob přípravy amlodipinuŹ jeho derivátů a jejich prekurzorů
|
WO2002053539A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Amlodipine hemimaleate
|
KR100374767B1
(ko)
*
|
2001-03-13 |
2003-03-03 |
한미약품공업 주식회사 |
개선된 암로디핀의 제조 방법
|
KR100452491B1
(ko)
*
|
2001-03-29 |
2004-10-12 |
한미약품 주식회사 |
신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
|
DE60235101D1
(de)
|
2001-07-06 |
2010-03-04 |
Lek Pharmaceuticals |
Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
|
US6680334B2
(en)
|
2001-08-28 |
2004-01-20 |
Pfizer Inc |
Crystalline material
|
GB0120808D0
(en)
*
|
2001-08-28 |
2001-10-17 |
Pfizer Ltd |
Crystalline material
|
US20030180354A1
(en)
*
|
2001-10-17 |
2003-09-25 |
Dr. Reddy's Laboratories Limited |
Amlodipine maleate formulations
|
US20040001886A1
(en)
*
|
2001-10-17 |
2004-01-01 |
Dr. Reddy's Laboratories Limited |
Stabilized pharmaceutical formulations containing amlodipine maleate
|
US6562983B1
(en)
*
|
2002-03-18 |
2003-05-13 |
Council Of Scientific And Industrial Research |
Process for the preparation of alkyl 4[2-(phthalimido)ethoxy]-acetoacetate
|
US20070135488A1
(en)
*
|
2002-04-13 |
2007-06-14 |
Chung You S |
Amlodipine nicotinate and process for the preparation thereof
|
US6699892B2
(en)
|
2002-06-04 |
2004-03-02 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salt of amlodipine and method of preparing the same
|
KR100496436B1
(ko)
*
|
2002-07-30 |
2005-06-20 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100538641B1
(ko)
*
|
2002-07-30 |
2005-12-22 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR20040011751A
(ko)
*
|
2002-07-30 |
2004-02-11 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100462304B1
(ko)
*
|
2002-07-30 |
2004-12-17 |
씨제이 주식회사 |
암로디핀의 유기산염
|
CN1681495B
(zh)
|
2002-08-19 |
2010-05-12 |
辉瑞产品公司 |
用于治疗过度增生性疾病的组合物
|
KR100467669B1
(ko)
*
|
2002-08-21 |
2005-01-24 |
씨제이 주식회사 |
암로디핀의 유기산염
|
US6784297B2
(en)
*
|
2002-09-04 |
2004-08-31 |
Kopran Limited |
Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
|
EP1537083A4
(de)
*
|
2002-09-11 |
2006-11-22 |
Hanlim Pharmaceutical Co Ltd |
S-(-)-amlodipinnicotinat und verfahren zu dessen herstellung
|
AU2003253460A1
(en)
*
|
2002-09-19 |
2004-04-08 |
Cj Corporation |
Crystalline organic acid salt of amlodipine
|
KR100596369B1
(ko)
|
2002-09-19 |
2006-07-03 |
씨제이 주식회사 |
결정형의 암로디핀 유기산염
|
US20040072879A1
(en)
*
|
2002-10-10 |
2004-04-15 |
Dr. Reddy's Laboratories Limited |
Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
|
WO2004058711A1
(en)
*
|
2002-12-30 |
2004-07-15 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. |
Isolation of dihydropyridine derivative and preparation salts thereof
|
DE10335027A1
(de)
*
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
KR101194453B1
(ko)
*
|
2003-01-31 |
2012-10-24 |
다이이찌 산쿄 가부시키가이샤 |
동맥 경화 및 고혈압증의 예방 및 치료를 위한 의약
|
US20050019395A1
(en)
*
|
2003-04-14 |
2005-01-27 |
Gabor Pragai |
Formulations of amlodipine maleate
|
WO2004093813A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
|
WO2004093816A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
|
DE112004000712T5
(de)
*
|
2003-04-25 |
2006-10-19 |
Cipla Ltd. |
Verfahren zur Herstellung von Amlodipinmesilat-Monohydrat
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
AU2004247023A1
(en)
*
|
2003-05-16 |
2004-12-23 |
Ambit Biosciences Corporation |
Heterocyclic compounds and uses thereof
|
CA2526730A1
(en)
*
|
2003-05-30 |
2004-12-09 |
Ranbaxy Laboratories Limited |
Substituted pyrrole derivatives
|
CA2532807A1
(en)
*
|
2003-07-17 |
2005-02-03 |
Cotherix, Inc. |
Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
|
US20050037063A1
(en)
*
|
2003-07-21 |
2005-02-17 |
Bolton Anthony E. |
Combined therapies
|
CH697952B1
(de)
*
|
2003-07-25 |
2009-03-31 |
Siegfried Generics Int Ag |
Verfahren zur Reinigung der freien Amlodipinbase.
|
WO2005023769A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Cipla Limited |
Process for the preparation of amlodipine salts
|
WO2005025507A2
(en)
*
|
2003-09-10 |
2005-03-24 |
Synta Phamaceuticals Corp. |
Dihydropyridine compounds for treating or preventing metabolic disorders
|
KR100841409B1
(ko)
*
|
2003-12-16 |
2008-06-25 |
에스케이케미칼주식회사 |
암로디핀 겐티세이트 염과 이의 제조방법
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
WO2005089353A2
(en)
*
|
2004-03-16 |
2005-09-29 |
Sepracor Inc. |
(s)-amlodipine malate
|
US7244765B2
(en)
*
|
2004-06-25 |
2007-07-17 |
Cytokine Pharmasciences, Inc |
Guanylhydrazone salts, compositions, processes of making and methods of using
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
WO2006003672A1
(en)
*
|
2004-07-02 |
2006-01-12 |
Matrix Laboratories Ltd |
Process for the preparation of pure amlodipine
|
JP2008507585A
(ja)
*
|
2004-07-26 |
2008-03-13 |
コセリックス インク |
微粒子製剤を用いて吸入したイロプロストによる肺高血圧症の治療
|
EA013053B1
(ru)
*
|
2004-11-05 |
2010-02-26 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Двуслойная таблетка, содержащая телмисартан и амлодипин
|
KR20070084455A
(ko)
*
|
2004-11-23 |
2007-08-24 |
워너-램버트 캄파니 엘엘씨 |
지질혈증 치료용 hmg co-a 환원효소 억제제로서의7-(2h-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체
|
EP1833466A1
(de)
*
|
2004-12-28 |
2007-09-19 |
Ranbaxy Laboratories Limited |
Verfahren zur herstelulng von stabilen pharmazeutischen soliden dosierformen von atorvastatin und amlodipin
|
US20080268049A1
(en)
*
|
2005-02-11 |
2008-10-30 |
Dhaliwal Mona |
Stable Solid Dosage Forms of Amlodipine and Benazepril
|
CN101247832B
(zh)
*
|
2005-06-27 |
2011-12-28 |
第一三共株式会社 |
含有血管紧张素ⅱ受体拮抗剂和钙通道阻断剂的药物制剂
|
CA2613875C
(en)
|
2005-07-04 |
2018-09-25 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
ES2265781B1
(es)
*
|
2005-08-04 |
2007-12-01 |
Ercros Industrial, S.A. |
Procedimiento para la obtencion de besilato de amlodipina.
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
ATE551059T1
(de)
|
2005-10-26 |
2012-04-15 |
Asahi Kasei Pharma Corp |
Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
|
EP2351569B1
(de)
|
2005-10-26 |
2012-08-22 |
Asahi Kasei Pharma Corporation |
Kombinationstherapie mit Fasudil zur Behandlung von pulmonaler Hypertonie
|
SG166829A1
(en)
*
|
2005-11-08 |
2010-12-29 |
Ranbaxy Lab Ltd |
Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
TW200736245A
(en)
*
|
2005-11-29 |
2007-10-01 |
Sankyo Co |
Acid addition salts of optically active dihydropyridine derivatives
|
TW200806648A
(en)
*
|
2005-11-29 |
2008-02-01 |
Sankyo Co |
Acid addition salts of dihydropyridine derivatives
|
US7919506B2
(en)
|
2006-03-10 |
2011-04-05 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
AR059838A1
(es)
*
|
2006-03-14 |
2008-04-30 |
Ranbaxy Lab Ltd |
Formulaciones para dosis estabilizantes de estatina
|
US20070260065A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Vijayabhaskar Bolugoddu |
Process for preparing amlodipine
|
BRPI0714361A2
(pt)
*
|
2006-07-14 |
2013-03-26 |
Ranbaxy Lab Ltd |
polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento
|
WO2008023869A1
(en)
*
|
2006-08-24 |
2008-02-28 |
Hanall Pharmaceutical Co., Ltd. |
Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
|
TWI399223B
(zh)
*
|
2006-09-15 |
2013-06-21 |
Daiichi Sankyo Co Ltd |
奧美沙坦酯及氨氯地平之固體劑型
|
US20080096863A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Torrent Pharmaceuticals Limited |
Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor
|
CN101167724B
(zh)
*
|
2006-10-25 |
2012-08-22 |
北京华安佛医药研究中心有限公司 |
含有氨氯地平的药物组合物在制备治疗下尿路疾病药物中的用途
|
KR100830003B1
(ko)
|
2006-10-31 |
2008-05-15 |
씨제이제일제당 (주) |
결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
|
ES2382009T3
(es)
|
2006-12-01 |
2012-06-04 |
Bristol-Myers Squibb Company |
Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
|
GB0624084D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amino acid salts
|
GB0624090D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amine salts
|
GB0624087D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril combination salt
|
CL2008000070A1
(es)
*
|
2007-01-17 |
2008-07-25 |
Lg Life Sciences Ltd |
Monosal del acido maleico (3-[({1-[(2-amino-9h-purin-9-il)metil]ciclopropil}oxi)metil]-8,8-dimetil-3,7-dioxo-2,4,6-trioxa-3 lambda 5-fosfanon-1-il-pivalato; composicion farmaceutica que comprende a dicha monosal; y uso para el tratamiento del virus h
|
CN101230035B
(zh)
*
|
2007-03-23 |
2010-11-03 |
浙江尖峰药业有限公司 |
门冬氨酸氨氯地平系列盐及其制备方法和其组合物、制剂以及片剂
|
EP1975167A1
(de)
*
|
2007-03-30 |
2008-10-01 |
Esteve Quimica, S.A. |
Acetonsolvat von Phthaloylamlodipin
|
US20080249141A1
(en)
*
|
2007-04-06 |
2008-10-09 |
Palepu Nageswara R |
Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
|
US20090062352A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched amlodipine
|
US8748648B2
(en)
*
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
PE20091156A1
(es)
*
|
2007-12-17 |
2009-09-03 |
Astrazeneca Ab |
Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
|
EP2240163A1
(de)
*
|
2007-12-31 |
2010-10-20 |
Lupin Limited |
Pharmazeutische zusammensetzungen von amlodipin und valsartan
|
EP2253318B1
(de)
*
|
2008-03-13 |
2014-08-06 |
Daiichi Sankyo Company, Limited |
Verbesserte auflösbarkeit eines präparats mit olmesartan-medoxomil
|
CN101560181B
(zh)
*
|
2008-04-16 |
2013-02-27 |
北京万全阳光医学技术有限公司 |
一种氨氯地平游离碱的制备方法
|
CN101367759B
(zh)
*
|
2008-10-06 |
2011-03-16 |
北京赛科药业有限责任公司 |
一种高纯度苯磺酸氨氯地平的合成方法
|
JP2010100562A
(ja)
*
|
2008-10-23 |
2010-05-06 |
Daito Kk |
アムロジピン製造中間体の精製方法
|
EP2437733A4
(de)
|
2009-06-02 |
2014-01-08 |
Dow Global Technologies Llc |
Retard-darreichungsform
|
EP2509596B1
(de)
|
2009-12-08 |
2019-08-28 |
Case Western Reserve University |
Gamma aminosäure zur behandlung von augenerkrankungen
|
WO2011117876A1
(en)
|
2010-03-26 |
2011-09-29 |
Fdc Limited |
An improved process for the preparation of amlodipine free base and acid addition salts thereof
|
IT1400309B1
(it)
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
|
WO2011149438A1
(en)
|
2010-05-28 |
2011-12-01 |
Mahmut Bilgic |
Combination of antihypertensive agents
|
EP2575757A1
(de)
|
2010-06-03 |
2013-04-10 |
Mahmut Bilgic |
Wasserlösliche formulierung mit einer kombination aus amlodipin und einem statin
|
WO2012037665A1
(en)
|
2010-09-24 |
2012-03-29 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
WO2012055941A1
(en)
|
2010-10-27 |
2012-05-03 |
Krka,Tovarna Zdravil, D. D., Novo Mesto |
Multilayer pharmaceutical composition comprising telmisartan and amlodipine
|
TR201100152A2
(tr)
|
2011-01-06 |
2012-07-23 |
Bi̇lgi̇ç Mahmut |
Amlodipin içeren efervesan bileşimler.
|
CN102070516A
(zh)
*
|
2011-02-22 |
2011-05-25 |
广东东阳光药业有限公司 |
一种制备氨氯地平的方法
|
WO2012123966A1
(en)
|
2011-03-04 |
2012-09-20 |
Arch Pharmalabs Limited |
Process for the preparation of 4 -substituted -1, 4-dihydropyridines
|
US8765776B2
(en)
|
2011-04-12 |
2014-07-01 |
Boryung Pharmaceutical Co., Ltd. |
Antihypertensive pharmaceutical composition
|
EP2747757A1
(de)
|
2011-08-26 |
2014-07-02 |
Wockhardt Limited |
Verfahren zur behandlung kardiovaskulärer erkrankungen
|
CN102382041B
(zh)
*
|
2011-12-02 |
2016-01-20 |
东北制药集团股份有限公司 |
一种马来酸氨氯地平的制备方法
|
PL236001B1
(pl)
|
2012-12-21 |
2020-11-30 |
Adamed Spolka Z Ograniczona Odpowiedzialnoscia |
Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
|
CN103044314A
(zh)
*
|
2013-01-06 |
2013-04-17 |
先声药业有限公司 |
马来酸氨氯地平的制备方法
|
JP5952748B2
(ja)
*
|
2013-01-25 |
2016-07-13 |
東和薬品株式会社 |
フタロイルアムロジピンの新規結晶形態およびそれを用いる高純度なアムロジピンベシル酸塩の製造方法
|
WO2014122585A1
(en)
|
2013-02-08 |
2014-08-14 |
Wockhardt Limited |
A stable pharmaceutical composition of amlodipine and benazepril or salts thereof
|
JP2016516804A
(ja)
|
2013-04-17 |
2016-06-09 |
ファイザー・インク |
心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体
|
EP3025711B1
(de)
|
2013-07-23 |
2020-11-18 |
Daiichi Sankyo Company, Limited |
Medikament zur vorbeugung oder behandlung von hypertonie
|
CN104262237A
(zh)
*
|
2014-09-28 |
2015-01-07 |
常州瑞明药业有限公司 |
氨氯地平自由碱的合成方法
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
CN104529877A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-癸酸离子液体及其制备方法和用途
|
CZ2015687A3
(cs)
|
2015-10-02 |
2017-04-12 |
Zentiva, K.S. |
Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu
|
WO2017068532A1
(en)
|
2015-10-23 |
2017-04-27 |
Ftf Pharma Private Limited |
Oral solution of dihydropyridine derivatives
|
EP3434284A4
(de)
|
2016-03-24 |
2019-11-13 |
Daiichi Sankyo Company, Limited |
Medizin zur behandlung von nierenerkrankung
|
US20200316029A1
(en)
|
2016-05-30 |
2020-10-08 |
Boehringer Ingelheim International Gmbh |
Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
|
ES2886067T3
(es)
|
2016-10-07 |
2021-12-16 |
Silvergate Pharmaceuticals Inc |
Formulaciones de amlodipina
|
US10350171B2
(en)
|
2017-07-06 |
2019-07-16 |
Dexcel Ltd. |
Celecoxib and amlodipine formulation and method of making the same
|
CN112334134A
(zh)
|
2018-04-11 |
2021-02-05 |
希沃盖特制药公司 |
氨氯地平制剂
|
AU2019287541A1
(en)
|
2018-06-14 |
2021-01-21 |
Astrazeneca Uk Limited |
Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
|
AU2019285170A1
(en)
|
2018-06-14 |
2021-01-28 |
Astrazeneca Uk Limited |
Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition
|
EP3911648A4
(de)
|
2019-01-18 |
2022-10-26 |
Astrazeneca AB |
Pcsk9-inhibitoren und verfahren zur verwendung davon
|
WO2020234348A1
(en)
|
2019-05-21 |
2020-11-26 |
Société des Produits Nestlé S.A. |
Dietary butyrate
|
GB2595203A
(en)
|
2020-03-03 |
2021-11-24 |
Alkaloid Ad Skopje |
Formulation
|
GB202102575D0
(en)
|
2021-02-23 |
2021-04-07 |
Teva Pharmaceutical Industries Ltd |
Fixed-dose pharmaceutical compositions
|